Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
ANIP ANI Pharmaceuticals
- 53.350
- -0.910-1.68%
Close Dec 20 16:00 ET
- 53.350
- 0.0000.00%
Post 20:01 ET
1.12BMarket Cap-113.51P/E (TTM)
54.560High53.000Low1.07MVolume53.690Open54.260Pre Close56.98MTurnover6.64%Turnover Ratio62.76P/E (Static)21.02MShares70.81052wk High2.76P/B856.39MFloat Cap52.50052wk Low--Dividend TTM16.05MShs Float392.040Historical High--Div YieldTTM2.88%Amplitude4.800Historical Low53.439Avg Price1Lot Size
About ANI Pharmaceuticals Company
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
Company Profile
SymbolANIP
Company NameANI Pharmaceuticals
Listing DateOct 1, 2003
Founded1996
CEOMr. Nikhil Lalwani
MarketNASDAQ
Employees642
Fiscal Year Ends12-31
Address210 Main Street West
CityBaudette
ProvinceMinnesota
CountryUnited States of America
Zip Code56623
Phone1-218-634-3500
Company Executives
- Name
- Position
- Salary
- Nikhil Lalwani
- Director, President and Chief Executive Officer
- 8.08M
- Stephen P. Carey
- Senior Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
- 2.58M
- Krista Davis
- Senior Vice President and Chief Human Resources Officer
- --
- James G. Marken
- Senior Vice President, Operations and Product Development
- --
- Chad Gassert
- Senior Vice President, Corporate Development and Strategy
- 1.90M
- Ori Gutwerg
- Senior Vice President, Generics
- 1.94M
- Thomas Rowland
- Senior Vice President, Corporate Development & Strategy
- --
- Meredith W. Cook
- Senior Vice President, General Counsel and Corporate Secretary
- --
- Christopher Mutz
- Senior Vice President and Head of Rare Diseases
- 1.91M
- Patrick D. Walsh
- Chairman of the Board
- 422.21K
- Muthusamy Shanmugam
- Director, Head of Research and Development and Chief Operating Office, Novitium Operations
- --
- Matthew J. Leonard
- Director
- 928.31K
- Thomas J. Haughey
- Independent Director
- 412.21K
- Jeanne Thomas
- Independent Director
- 395.75K
- Antonio R. Pera
- Independent Director
- 393.25K
- Dr. Renee P. Tannenbaum, D.Pharm.
- Independent Director
- 392.37K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.